Response To: Chiari Malformation Type 0: Methodological Concerns Regarding the Null Structural Finding - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Reply to: Methodological Issues in the Structural Analysis of Chiari Malformation Type 0

  • By

  • B. Candan

  • B. Ozkal

  • E. Top

  • August 15, 2026

Share

  • 1

    The classification of Chiari malformation type 0 (CM-0) is not universally recognized and is characterized by Chiari-like symptoms and minimal tonsillar descent.

  • 2

    The study aimed to assess a broader range of CM-0 patients rather than replicate studies focusing solely on those with syringomyelia.

  • 3

    None of the observed morphometric differences between CM-0 patients and controls achieved statistical significance after corrections for multiple comparisons.

  • 4

    The authors acknowledge limitations in their study, including reliance on two-dimensional measurements and lack of standardized cerebrospinal fluid flow studies.

  • 5

    Future research should explore morphometry, cerebrospinal fluid dynamics, and symptomatology to better understand the CM-0 classification.

Original Source(s)

Response To: Chiari Malformation Type 0: Methodological Concerns Regarding the Null Structural Finding

  • by B. Candan, B. Ozkal, E. Top

  • August 15, 2026

Related Content

FDA Clears Exoskeleton for Spinal Cord Injury

Use is limited to level indoor and adjoining outdoor areas and requires supervision by a companion with specialized training.

FDA approves tau PET imaging agent

The F18-labeled agent is indicated for brain PET imaging to identify tau neurofibrillary tangle pathology.

Can SGLT2 Inhibitors Affect Dementia?

A target trial emulation using Veterans Affairs electronic health records examined neuropsychiatric outcomes associated with SGLT2 inhibitor use.